首站-论文投稿智能助手
典型文献
Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma
文献摘要:
Glioblastoma(GBM)therapy is severely impaired by the blood-brain barrier(BBB)and invasive tumor growth in the central nervous system.To improve GBM therapy,we herein presented a dual-targeting nanotheranostic for second near-infrared(NIR-Ⅱ)fluorescence imaging-guided photo-immunotherapy.Firstly,a NIR-Ⅱ fluorophore MRP bearing donor-acceptor-donor(D-A-D)backbone was synthesized.Then,the prodrug nanotheranostics were prepared by self-assembling MRP with a pro-drug of JQ1(JPC)and T7 ligand-modified PEG5k-DSPE.T7 can cross the BBB for tumor-targeted de-livery of JPC and MRP.JQ1 could be restored from JPC at the tumor site for suppressing interferon gamma-inducible programmed death ligand 1 expression in the tumor cells.MRP could generate NIR-Ⅱ fluorescence to navigate 808 nm laser,induce a photothermal effect to trigger in-situ antigen release at the tumor site,and ultimately elicit antitumor immunogenicity.Photo-immunotherapy with JPC and MRP dual-loaded nanoparticles remarkably inhibited GBM tumor growth in vivo.The dual-targeting na-notheranostic might represent a novel nanoplatform for precise photo-immunotherapy of GBM.
文献关键词:
作者姓名:
Fenglin Li;Yi Lai;Jiayi Ye;Madiha Saeed;Yijing Dang;Zhifeng Zou;Fangmin Chen;Wen Zhang;Zhiai Xu
作者机构:
School of Chemistry and Molecular Engineering,East China Normal University,Shanghai 200241,China;State Key Laboratory of Drug Research&Center of Pharmaceutics,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China
引用格式:
[1]Fenglin Li;Yi Lai;Jiayi Ye;Madiha Saeed;Yijing Dang;Zhifeng Zou;Fangmin Chen;Wen Zhang;Zhiai Xu-.Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma)[J].药学学报(英文版),2022(09):3486-3497
A类:
PEG5k,notheranostic
B类:
Dual,targeting,prodrug,nanotheranostics,NIR,fluorescence,imaging,guided,immunotherapy,glioblastoma,Glioblastoma,GBM,severely,impaired,by,blood,brain,barrier,BBB,invasive,growth,central,nervous,system,To,improve,herein,presented,dual,second,near,infrared,Firstly,fluorophore,MRP,bearing,donor,acceptor,backbone,was,synthesized,Then,were,prepared,self,assembling,JQ1,JPC,T7,ligand,modified,DSPE,can,cross,targeted,livery,could,restored,from,site,suppressing,interferon,gamma,inducible,programmed,death,expression,cells,generate,navigate,laser,induce,photothermal,effect,trigger,situ,antigen,release,ultimately,elicit,antitumor,immunogenicity,Photo,loaded,nanoparticles,remarkably,inhibited,vivo,might,represent,novel,nanoplatform,precise
AB值:
0.56237
相似文献
Targeting the Rac1 pathway for improved prostate cancer therapy using polymeric nanoparticles to deliver of NSC23766
Zean Li;Jun Huang;Tao Du;Yiming Lai;Kaiwen Li;Man-Li Luo;Dingjun Zhu;Jun Wu;Hai Huang-Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510220,China;Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Medical Research Center,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;School of Biomedical Engineering,Sun Yat-sen University,Shenzhen 518107,China;Department of Obstetrics and Gynecology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Urology,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China
A novel peptide-based probe 99mTc-PEG6-RD-PDP2 for the molecular imaging of tumor PD-L2 expression
Qi Luo;Yunwei Zhang;Zihua Wang;Yining Sun;Linqing Shi;Yue Yu;Jiyun Shi;Zhiyuan Hu;Fan Wang-Guangzhou Laboratory,Guangzhou 510005,China;Medical Isotopes Research Center and Department of Radiation Medicine,State Key Laboratory of Natural and Biomimetic Drugs,School of Basic Medical Sciences,Peking University,Beijing 100191,China;Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases,School of Basic Medical Sciences,Fujian Medical University,Fuzhou 350122,China;Key Laboratory of Protein and Peptide Pharmaceuticals,CAS Center for Excellence in Biomacromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;CAS Key Laboratory of Standardization and Measurement for Nanotechnology,CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety,CAS Center for Excellence in Nanoscience,National Center for Nanoscience and Technology of China,Beijing 100190,China
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
Jingjing He;Xinxin Xiong;Han Yang;Dandan Li;Xuefei Liu;Shuo Li;Shuangye Liao;Siyu Chen;Xizhi Wen;Kuai Yu;Lingyi Fu;Xingjun Dong;Kaiyu Zhu;Xiaojun Xia;Tiebang Kang;Chaochao Bian;Xiang Li;Haiping Liu;Peirong Ding;Xiaoshi Zhang;Zhenjiang Liu;Wende Li;Zhixiang Zuo;Penghui Zhou-State Key Laboratory of Oncology in Southern China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University Cancer Center,Guangzhou,China;Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou,China;Guangdong Laboratory Animals Monitoring Institute,Guangdong Key Laboratory of Laboratory Animals,Guangzhou,China;Guangzhou Finelmmune Biotechnology Co.,LTD,Guangzhou,China
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-cai Xu;Li Yang;Pei-quan Zhang;Ding Yan;Qian Xue;Qing-tian Huang;Xiao-fen Li;Ya-li Hao;Dao-lin Tang;Q.Ping Dou;Xin Chen;Jin-bao Liu-Affliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;The Department of Physiology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550003,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。